Joseph Michael Fitzgerald
At a glance: Joseph Michael Fitzgerald is Evp & Group Pres, Cardiology at Boston Scientific (BSX). Their latest SEC Form 4, filed Nov 4, 2025, reported a sale of $363K. On file: 0 purchase lines ($0) and 5 sale lines ($9.9M).
Disclosed holdings: about $7.6M of BSX stock: 178,342 shares reported on their latest Form 4 (filed Nov 4, 2025), valued at the Nov 20, 2026 close of $42.72. This counts only BSX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp & Group Pres, Cardiology at Boston Scientific Corp (BSX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Joseph Michael Fitzgerald's InsiderPrint
5 trades from SEC Form 4 filings, 2025 to 2025, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 5 times a year, typically $1.7M a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (5)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Michael G. BarrettCEO · MGNI · 100% match
- Donald E. SimmonsPresident · TT · 100% match
- Carl DambkowskiDirector · ORKA · 100% match
- Timothy L. ChambersSr Vp & Pres - Tools · SNA · 100% match
- Adam M. VenessGeneral Counsel · DNTH · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 4SEC | BSXBoston Scientific Corp | Sell Plan | 3,600224,742 held (−2%) | $100.75 | $363K | -57.6% |
| Nov 4SEC | BSXBoston Scientific Corp | Sell Plan | 16,928207,814 held (−8%) | $99.76 | $1.7M | -57.2% |
| Nov 4SEC | BSXBoston Scientific Corp | Sell Plan | 29,472178,342 held (−14%) | $99.14 | $2.9M | -56.9% |
| Oct 1SEC | BSXBoston Scientific Corp | Sell Plan | 8,245220,097 held (−4%) | $98.91 | $816K | -56.8% |
| Oct 1SEC | BSXBoston Scientific Corp | Sell Plan | 41,755178,342 held (−19%) | $98.38 | $4.1M | -56.6% |
- Sell
Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $363K of BSX at $100.75 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $1.7M of BSX at $99.76 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $2.9M of BSX at $99.14 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $816K of BSX at $98.91 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Group Pres, Cardiology Joseph Michael Fitzgerald sold $4.1M of BSX at $98.38 — pre-scheduled 10b5-1 plan sale.
Follow Joseph Michael Fitzgerald
Get one email when Joseph Michael Fitzgerald files a new purchase or sale. Free.
At most one email a day about Joseph Michael Fitzgerald, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.